Macro works with sponsors and CROs to execute clinical trials for high-value therapeutics. Macro creates access for diverse candidates and partners with clinicians looking to stay on the forefront of care.

Macro

Macro Trials is the precision research clinical platform, driving increased research velocity and an amplified patient experience to unlock value for all stakeholders in the clinical trial ecosystem. Via its digitally powered infrastructure and "hub-and-spoke" distributed model, Macro partners with pharmaceutical companies, CROs, providers, and health systems to conduct trials for high-value therapeutics. The company’s turnkey platform empowers physicians to participate in groundbreaking research via workflow-native efficiency tools, clinical research personnel and a network of logistic partners. Macro’s clinical trial intelligence platform and proprietary real-world evidence as a service (RWEaaS) product supports life sciences companies in all aspects of therapeutic research, development, and commercialization.

MBX Capital

Village Global

Healthy Ventures

Inflect Health

Initiate Ventures

Macro Trials

We're #hiring a new Director of Clinical Operations in Los Angeles County, California. Apply today or share this post with your network.

Macro Trials is running a clinical study to determine if treatment with OnabotulinumtoxinA (BOTOX) to the facial musculature has any effect on patient-perceived stress levels, led by world-renowned Facial Plastic Surgeon Babak Azizzadeh, MD, FACS (Clinical Chief at Cedars Sinai & Director of Center for Advanced Facial Plastic Surgery) as Principal Investigator.

For more information, please fill out this form: https://lnkd.in/ehyGis7d

Or contact us directly at 747-288-6530 & bhernandez@macrotrials.com

Metric
Company Name	Macro
Symbol
MSH ID	COM:MACROTRIALS
Market	PRIVATE
Sector	Healthcare & Health Services
Industry	Clinical Research
Country	US
Stage
Employee Count	18
Website	macrotrials.com
LinkedIn	macrotrials
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic	4.88K
Web Traffic Growth	0.18
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

COM:MACROTRIALS

Macro

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue